3PBIOVIAN strengthens its Leadership team with the appointment of a Business Development Director for Advanced Therapies October 9, 2024 Read more >
3PBIOVIAN receives the Talent Acceleration Award at the 2024 BWB Awards in Boston September 25, 2024 Read more >
3PBIOVIAN strengthens its executive team with the appointment of three new directors September 19, 2024 Read more >
Rokote Laboratories signs an agreement with 3PBIOVIAN for GMP manufacturing of adenovirus vector-based COVID-19 vaccine August 29, 2024 Read more >
Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO February 1, 2024 Read more >
3P Biopharmaceuticals: building a legacy of innovation and excellence in biotechnology December 20, 2023 Read more >
Biovian announces the successful refinancing of its existing debt package and the securing of new funding to support GeneCity facility expansion December 18, 2023 Read more >
3P Biopharmaceuticals and the University of Navarra bring the Neanderthal world and biomedicine to the public in a successful event. October 19, 2023 Read more >
3P Biopharmecuiticals celebrates cerebral palsy day in collaboration with ASPACE October 6, 2023 Read more >